Vitamin E Levels and Mortality in HIV-1-Infected Women
Author Information
Author(s): Graham Susan M, Baeten Jared M, Richardson Barbra A, Bankson Daniel D, Lavreys Ludo, Ndinya-Achola Jeckoniah O, Mandaliya Kishorchandra, Overbaugh Julie, McClelland R Scott
Primary Institution: University of Washington
Hypothesis
Vitamin E levels at HIV-1 acquisition may influence disease progression.
Conclusion
Higher pre-infection vitamin E levels were associated with increased mortality.
Supporting Evidence
- Each 1 mg/L increase in pre-infection vitamin E was associated with a 1.58-fold higher risk of mortality.
- The median pre-infection vitamin E level was in the low-normal range (7.5 mg/L).
- The prevalence of vitamin E deficiency (<5 mg/L) was 21% among participants.
Takeaway
Women with higher vitamin E levels before getting HIV were more likely to die from the disease.
Methodology
Vitamin E status was measured in stored samples from the last pre-infection visit for 67 Kenyan women, and regression analyses were used to estimate associations.
Potential Biases
Potential confounding factors such as socioeconomic status may have influenced the results.
Limitations
CD4 cell counts were not available before April 1998, and the cause of death was unknown for most women.
Participant Demographics
Kenyan women, median age 28 years, with a median of 1 live birth and varying education levels.
Statistical Information
P-Value
0.004
Confidence Interval
95% CI 1.15–2.16
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website